原发性甲状腺功能减退症并接受适当左甲状腺素替代治疗的肥胖女性的静息能量消耗
该回顾性分析纳入2013年1月至2019年7月单中心肥胖门诊的649例非糖尿病女性(BMI>30 kg/m²,TSH 0.4-4.0 mU/L),分为原发性甲减接受左甲状腺素治疗组(n=85)和甲状腺功能正常对照组(n=564)。结果显示甲减治疗组静息能量消耗(REE)较对照组降低(28.59 ± 3.26 vs 29.91 ± 3.59 kcal/kg去脂体重/天),校正年龄、BMI、体成分和体力活动后仍显著(P=0.008),仅在校正HOMA-IR后差异减弱。
要点
- 肥胖原发性甲减女性在接受左甲状腺素治疗且TSH正常时,REE仍低于甲状腺功能正常者。
- REE差异在校正年龄、BMI、体成分和体力活动后仍显著(P=0.008)。
- 仅在校正HOMA-IR后该代谢差异减弱,提示胰岛素敏感性可能参与其中。
核心结论
- 接受左甲状腺素治疗且血清TSH正常的肥胖甲减女性,与甲状腺功能正常对照相比REE降低,符合标准左甲状腺素替代治疗可能未完全纠正甲减相关代谢改变的假设。
- 作者不能排除该特征受左甲状腺素口服给药诱导的肝脏胰岛素敏感性调节的影响。
研究设计与样本
- 回顾性分析2013年1月至2019年7月单中心肥胖门诊就诊的肥胖女性数据。
- 共纳入649例非糖尿病女性,BMI>30 kg/m²且TSH 0.4-4.0 mU/L,分为原发性甲减接受左甲状腺素治疗组(n=85)和甲状腺功能正常对照组(n=564)。
- 主要结局为间接测热法评估的REE和生物电阻抗评估的体成分。
主要发现
- 甲减治疗组REE为28.59 ± 3.26 kcal/kg FFM/天,对照组为29.91 ± 3.59 kcal/kg FFM/天,甲减治疗组较对照组降低。
- 校正年龄、BMI、体成分和体力活动水平后,REE差异仍显著(P=0.008)。
- 仅在校正HOMA-IR后该代谢差异减弱。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Growing evidence suggests that appropriate levothyroxine (LT4) replacement therapy may not correct the full set of metabolic defects afflicting individuals with hypothyroidism. OBJECTIVE: To assess whether obese subjects with primary hypothyroidism are characterized by alterations of the resting energy expenditure (REE). DESIGN: Retrospective analysis of a set of data about obese women attending the outpatients service of a single obesity center from January 2013 to July 2019. PATIENTS: A total of 649 nondiabetic women with body mass index (BMI) > 30 kg/m2 and thyrotropin (TSH) level 0.4-4.0 mU/L were segregated into 2 groups: patients with primary hypothyroidism taking LT4 therapy (n = 85) and patients with normal thyroid function (n = 564). MAIN OUTCOMES: REE and body composition assessed using indirect calorimetry and bioimpedance. RESULTS: REE was reduced in women with hypothyroidism in LT4 therapy when compared with controls (28.59 ± 3.26 vs 29.91 ± 3.59 kcal/kg fat-free mass (FFM)/day), including when adjusted for age, BMI, body composition, and level of physical activity (P = 0.008). This metabolic difference was attenuated only when adjustment for homeostatic model assessment of insulin resistance (HOMA-IR) was performed. CONCLUSIONS: This study demonstrated that obese hypothyroid women in LT4 therapy, with normal serum TSH level compared with euthyroid controls, are characterized by reduced REE, in line with the hypothesis that standard LT4 replacement therapy may not fully correct metabolic alterations related to hypothyroidism. We are not able to exclude that this feature may be influenced by the modulation of insulin sensitivity at the liver site, induced by LT4 oral administration.
引用
- Muraca E, Ciardullo S, Oltolini A, et al. Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy. J Clin Endocrinol Metab. 2020. PMID: 32119074. doi:10.1210/clinem/dgaa097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。